Accuray Inc: Form 10-Q for the period ended Mar 31, 2024
Filed with the SEC on May 8, 2024 and accepted by EDGAR at May 8, 2024, 16:22 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-01-01 to 2024-03-31 | $101.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-07-01 to 2024-03-31 | $312.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-01-01 to 2024-03-31 | $72.1m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2023-07-01 to 2024-03-31 | $207.8m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2024-01-01 to 2024-03-31 | $29.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2023-07-01 to 2024-03-31 | $104.5m | us-gaap:GrossProfit |
| Research and development | 3 months2024-01-01 to 2024-03-31 | $10.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2023-07-01 to 2024-03-31 | $40.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-01-01 to 2024-03-31 | −$4.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-07-01 to 2024-03-31 | −$6.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-01-01 to 2024-03-31 | $2.9m | us-gaap:InterestExpense |
| Interest expense | 9 months2023-07-01 to 2024-03-31 | $8.7m | us-gaap:InterestExpense |
| Income tax | 3 months2024-01-01 to 2024-03-31 | $444.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-07-01 to 2024-03-31 | $3.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-01-01 to 2024-03-31 | −$6.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-07-01 to 2024-03-31 | −$18.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-01-01 to 2024-03-31 | −$0.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-07-01 to 2024-03-31 | −$0.19 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-01-01 to 2024-03-31 | −$0.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-07-01 to 2024-03-31 | −$0.19 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-01-01 to 2024-03-31 | 99,197,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-07-01 to 2024-03-31 | 97,838,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-07-01 to 2024-03-31 | −$21.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-07-01 to 2024-03-31 | $3.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-03-31 | $60.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-03-31 | $313.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-03-31 | $462.5m | us-gaap:Assets |
| Current liabilities | At period end2024-03-31 | $198.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-03-31 | $421.4m | us-gaap:Liabilities |
| Long-term debt | At period end2024-03-31 | $166.2m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-03-31 | $7.2m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2024-03-31 | $7.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-03-31 | $41.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-055736. Last ingested by Listed: Nov 4, 2026, 17:17 ET. Listed shows no prices and gives no investment advice.